These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 25661544)

  • 1. Application of Modular Therapy for Renoprotection in Experimental Chronic Kidney Disease.
    Kepecs DM; Zhang Y; Thai K; Advani SL; Yuen DA; Connelly KA; Kosanam H; Diamandis E; Sefton MV; Gilbert RE
    Tissue Eng Part A; 2015 Jul; 21(13-14):1963-72. PubMed ID: 25661544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early outgrowth cells release soluble endocrine antifibrotic factors that reduce progressive organ fibrosis.
    Yuen DA; Connelly KA; Zhang Y; Advani SL; Thai K; Kabir G; Kepecs D; Spring C; Smith C; Batruch I; Kosanam H; Advani A; Diamandis E; Marsden PA; Gilbert RE
    Stem Cells; 2013 Nov; 31(11):2408-19. PubMed ID: 23922321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated treatment with bone marrow cell secretory products maintains long-term renoprotection in experimental chronic kidney disease: a placebo-controlled trial.
    Yuen DA; Kepecs DM; Zhang Y; Advani S; Thai K; Connelly KA; Gilbert RE
    Can J Kidney Health Dis; 2015; 2():44. PubMed ID: 26568839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Healthy bone marrow cells reduce progression of kidney failure better than CKD bone marrow cells in rats with established chronic kidney disease.
    van Koppen A; Joles JA; Bongartz LG; van den Brandt J; Reichardt HM; Goldschmeding R; Nguyen TQ; Verhaar MC
    Cell Transplant; 2012; 21(10):2299-312. PubMed ID: 23231961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of four-and-a-half LIM domain protein-2 increases survival, migratory capacity, and paracrine function of human early outgrowth cells through activation of the sphingosine kinase-1 pathway: implications for endothelial regeneration.
    Ebrahimian T; Arfa O; Simeone S; Lemarié CA; Lehoux S; Wassmann S
    Circ Res; 2014 Jan; 114(1):114-23. PubMed ID: 24084691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteogenesis of heterotopically transplanted mesenchymal stromal cells in rat models of chronic kidney disease.
    Kramann R; Kunter U; Brandenburg VM; Leisten I; Ehling J; Klinkhammer BM; Knüchel R; Floege J; Schneider RK
    J Bone Miner Res; 2013 Dec; 28(12):2523-34. PubMed ID: 23703894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo exposure of bone marrow from chronic kidney disease donor rats to pravastatin limits renal damage in recipient rats with chronic kidney disease.
    van Koppen A; Papazova DA; Oosterhuis NR; Gremmels H; Giles RH; Fledderus JO; Joles JA; Verhaar MC
    Stem Cell Res Ther; 2015 Apr; 6(1):63. PubMed ID: 25889756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble CD40 ligand impairs the function of peripheral blood angiogenic outgrowth cells and increases neointimal formation after arterial injury.
    Hristov M; Gümbel D; Lutgens E; Zernecke A; Weber C
    Circulation; 2010 Jan; 121(2):315-24. PubMed ID: 20048211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Injured kidney endothelium is only marginally repopulated by cells of extrarenal origin.
    Schirutschke H; Vogelbacher R; Stief A; Parmentier S; Daniel C; Hugo C
    Am J Physiol Renal Physiol; 2013 Oct; 305(7):F1042-52. PubMed ID: 23884147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Damage of the endothelial glycocalyx in chronic kidney disease.
    Padberg JS; Wiesinger A; di Marco GS; Reuter S; Grabner A; Kentrup D; Lukasz A; Oberleithner H; Pavenstädt H; Brand M; Kümpers P
    Atherosclerosis; 2014 Jun; 234(2):335-43. PubMed ID: 24727235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy of mesenchymal stem cells and serelaxin effectively attenuates renal fibrosis in obstructive nephropathy.
    Huuskes BM; Wise AF; Cox AJ; Lim EX; Payne NL; Kelly DJ; Samuel CS; Ricardo SD
    FASEB J; 2015 Feb; 29(2):540-53. PubMed ID: 25395452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic allograft nephropathy in rats is improved by the intervention of rhein.
    Su J; Yin LP; Zhang X; Li BB; Liu L; Li H
    Transplant Proc; 2013; 45(6):2546-52. PubMed ID: 23953579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The balance of beneficial and deleterious effects of hypoxia-inducible factor activation by prolyl hydroxylase inhibitor in rat remnant kidney depends on the timing of administration.
    Yu X; Fang Y; Liu H; Zhu J; Zou J; Xu X; Jiang S; Ding X
    Nephrol Dial Transplant; 2012 Aug; 27(8):3110-9. PubMed ID: 22399494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tanshinone IIA attenuates renal fibrosis and inflammation via altering expression of TGF-β/Smad and NF-κB signaling pathway in 5/6 nephrectomized rats.
    Wang DT; Huang RH; Cheng X; Zhang ZH; Yang YJ; Lin X
    Int Immunopharmacol; 2015 May; 26(1):4-12. PubMed ID: 25744602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of renal sympathetic nerve overactivation in the progression of chronic kidney disease in rats.
    Kobuchi S; Tanaka R; Funai A; Suzuki R; Yazawa M; Tsutsui H; Ohkita M; Ayajiki K; Matsumura Y
    J Cardiovasc Pharmacol; 2014 Jan; 63(1):9-15. PubMed ID: 24084211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progenitor cells and vascular function are impaired in patients with chronic kidney disease.
    Jie KE; Zaikova MA; Bergevoet MW; Westerweel PE; Rastmanesh M; Blankestijn PJ; Boer WH; Braam B; Verhaar MC
    Nephrol Dial Transplant; 2010 Jun; 25(6):1875-82. PubMed ID: 20083473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic fitness of primary endothelial cells cultured from patients with high cardiovascular risk or chronic kidney disease for vascular tissue engineering.
    Geenen IL; Verbruggen S; Molin DG; Spronk HM; Maessen JG; Meesters B; Schurink GW; Post MJ
    Tissue Eng Part A; 2014 Mar; 20(5-6):1049-59. PubMed ID: 24279825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone morphogenetic protein-5 and early endothelial outgrowth cells (eEOCs) in acute ischemic kidney injury (AKI) and 5/6-chronic kidney disease.
    Patschan D; Schwarze K; Lange A; Meise N; Henze E; Becker JU; Patschan S; Müller GA
    Am J Physiol Renal Physiol; 2013 Aug; 305(3):F314-22. PubMed ID: 23678046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble CD40 ligand impairs the anti-platelet function of peripheral blood angiogenic outgrowth cells via increased production of reactive oxygen species.
    Bou Khzam L; Hachem A; Zaid Y; Boulahya R; Mourad W; Merhi Y
    Thromb Haemost; 2013 May; 109(5):940-7. PubMed ID: 23426185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem cells in kidney diseases.
    Soler MJ; José Tomas OP
    J Stem Cells; 2012; 7(4):245-59. PubMed ID: 24196799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.